Mark A. Asbury J.D. serves as Chief Legal Officer and General Counsel of the Company. From 2016 to 2017, Mr. Asbury was General Counsel at Samsara BioCapital, a science-driven venture capital firm. From 2014 to 2016 Mr. Asbury was Chief Legal Officer and General Counsel at ZS Pharma (acquired by AstraZeneca) where he was responsible for all legal aspects of the organization, including intellectual property, SEC matters and strategic transactions. Prior to ZS Pharma, he was the Vice President and General Counsel of Pharmacyclics where he helped the company negotiate a $975 million deal with Johnson & Johnson for ibrutinib, its Phase 2 molecule. Prior to that, Mr. Asbury held a variety of positions at Genentech, most recently as Associate General Counsel and Senior Director of Transactional Law. Prior to joining Genentech, he worked for the law firm of Shearman & Sterling, where he specialized in corporate finance, mergers and acquisitions, and commercial debt financings. Mr. Asbury holds a B.A. in Soviet Studies from Vanderbilt University and a J.D. from Stanford Law School.
As the Chief Legal Officer and General Counsel of Allakos Inc, the total compensation of Mark Asbury at Allakos Inc is $4,664,770. There are 4 executives at Allakos Inc getting paid more, with Robert Alexander having the highest compensation of $12,559,300.
Mark Asbury is 56, he's been the Chief Legal Officer and General Counsel of Allakos Inc since 2018. There are 5 older and 5 younger executives at Allakos Inc. The oldest executive at Allakos Inc is Steven James, 62, who is the Independent Director.
Mark's mailing address filed with the SEC is 975 ISLAND DRIVE, SUITE 201, , REDWOOD CITY, CA, 94065.
Over the last 6 years, insiders at Allakos Inc have traded over $246,100,922 worth of Allakos Inc stock and bought 5,181,222 units worth $35,384,176 . The most active insiders traders include Paul Edward Walker, Group, Llc Green Jeremy Red..., and Daniel Janney. On average, Allakos Inc executives and independent directors trade stock every 43 days with the average trade being worth of $114,372. The most recent stock trade was executed by Harlan Baird Radford on 28 June 2024, trading 87,064 units of ALLK stock currently worth $87,935.
allakos inc is a biotechnology company located in 7400 paseo padre pkwy, fremont, ca, united states.
Allakos Inc executives and other stock owners filed with the SEC include: